TGF IVS: Financial statements 2019

CVR: 38795694

TGF IVS (CVR 38795694) has filed annual accounts for 2019. In 2019, the company reported revenue of DKK 5,000 and a net result of DKK 5,000. The profit margin was 100%. Equity amounted to DKK 1,000. The solvency ratio was 15.4%.

Revenue: 5,000 kr.
Gross Profit: 0 kr.
Profit/Loss: 5,000 kr.
Equity: 1,000 kr.
Total Assets: 6,500 kr.

Official annual report

View the official annual report directly on the page with a Pro subscription.

Fetch this data via API

Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.

See the API documentation

Events in 2019

TGF IVS publishes interim reportJun 6, 2019

TGF IVS has published its interim report for the period July 1, 2017 – December 31, 2018.

Morten Ingemann Andersen joins TGF IVS as directorJan 30, 2019

As of January 30, 2019, Morten Ingemann Andersen is registered as director of TGF IVS.

Henrik Selchau Poulsen steps down as liquidator of TGF IVSJan 30, 2019

As of January 30, 2019, Henrik Selchau Poulsen has stepped down as liquidator of TGF IVS.

TGF IVS exits liquidationJan 30, 2019

On January 30, 2019, TGF IVS exited liquidation.

About TGF IVS

TGF IVS was a Danish company of the type Iværksætterselskab based in København Ø, founded in 2017 and dissolved in 2022. The company was registered under the industry Ikke-finansielle holdingselskaber. In 2019, the company reported revenue of DKK 5,000 and a net result of DKK 5,000. Equity amounted to DKK 1,000.